Asbestos related cancer treatment breakthrough

Updated July 20 2021 - 9:38am, first published 1:00am
Keith Horwood said the reimbursement of a new therapy represents a significant milestone for Australians living with this devastating disease.
Keith Horwood said the reimbursement of a new therapy represents a significant milestone for Australians living with this devastating disease.

Australians living with inoperable malignant mesothelioma - a rare and aggressive cancer mainly due to asbestos exposure - are set to access the nation's first reimbursed immunotherapy for this cancer.

Get the latest Senior news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.